-+ 0.00%
-+ 0.00%
-+ 0.00%

Quoin Pharmaceuticals Q4 EPS $(1.74) Beats $(4.02) Estimate

Benzinga·03/26/2026 12:32:11
Listen to the news
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.74) per share which beat the analyst consensus estimate of $(4.02) by 56.72 percent. This is a 85.96 percent increase over losses of $(12.39) per share from the same period last year.